LOLOLOLOLOLOLOLOL!!!!!!!!!!! JERRY THINKS THE FBI WILL BE INVOLVED BECAUSE SOMEONE IS USING PUBLIC PHOTOS AS THEIR AVITAR....ERMMMMM OKAY STUPID FKKK. HOPE YOU DON'T REPRODUCE BECAUSE YOU ARE ONE STUPID MOHTER FKKER
Buyout coming soon. This will be a 410-412 buyout. Load up while you can.
So Jerry has 8 IDs running this board now?
POSTCARD FROM AEGIS CAPITAL CORPORATION DID ANYONE ELSE GET ONE IN REFERENCE TO MANNKIND?
Hamburger Humper Shorty: New on Twitter: Mom's A1C drops to 6.3! Nothing in two years came close to Afrezza. T1 since '83. Nice Tints !! [No Stalking Humpy.] https://twitter.com/Reen910
Laureen (@Reen910) | Twitter
The latest Tweets from Laureen (@Reen910). Living the dream....Six Sigma guru, mother, type 1 diabetic (diag 5/23/83), afrezza user and advocate (since March 2015)! Life moves pretty fast, don't miss it!. United States
Six months from now shorty bashers will all claim they are longs and have been for decades.
so why does this Jerry guy care so much about this message board? He must have a small pee pee. LOL!
This is a shorts dream. Up on no news. Huge correction coming. Trade accordingly
One Drop Launches New 'Plus' Subscriptions, Releases One Drop | Experts Worldwide, Expands Shipments To United Kingdom & European Union
9&10 News, Northern Michigan's News Leader is your online source for News, Breaking News, Weather, Michigan Sports, and Events.
Shorted more. Hopium pumpers throwing everything they got at this
BO minimum of $1-2 billion. Afrezza is still a potential blockbuster. The best way to sell Afrezza is to NOT compete with injectibles but use its uniqueness to market itself. NO needles, no need for refrigeration, ease of usage-- these are ideals for travels. Big Pharma can buyout Afrezza, do a short term usage for 1-2 weeks and prove no decrease in lung function, then file with the FDA to lift off spirometer requirement. These should be easy short 1-2 weeks studies, get the patients off for 3-4 months then get them on for another 1-2 weeks.
INHALE PULMONARY HYPERTENSION- this is a sure blockbuster, works at the site. A recent approved pill for pulm htn was sold for $8 billion. Imagine what inhalation would sell for, especially it works at the site.
INHALE EPI- current injectibles are $300-1000 per pen. imagine how lucrative an inhalation would be that works at the site where needed and it faster in onset.
It would be laughable if this company is sold for less than a $1 billion.
Blood Sugar from 335 to 120 in 1 hour. AFREZZA is the FASTEST Insulin!
Please share this video with any diabetic or medical professional. Thanks Eric
Why has Mann Group been pouring money into this company? Al Mann never thought twice that Afrezza would fail. If he did, he would have offered secondary to gain more cash before SNY partnership, that was trading at $50 (factored in the 5:1 reverse split). They could have sold 50-100 million shares to make $500 million, this would have easily gave them a lot of protection against SNY sabotage. Mann had too much faith in Afrezza and too much trust in SNY (but then again SNY changed CEO immediately after the partnership).
THE LID IS ABOUT TO BLOW...PRESSURE IS BUILDING...COMMENCE COUNTDOWN...DYODD
do I hear a 1.50?
My purchases at 70 cents are growing nicely. Thanks 🙏
Shorts fail to hold MNKD down...pressure continues to build...dyodd
No matter what way you try to spin it, RX numbers still nothing short of PATHETIC! Baseline rx in the 200 range BEFORE MNKD dedicated sales force hit the ground. Just to give you a reference, Humalog (AFrezza's closet competing insulin) had a weekly rx of over 30,000 THIRTY THOUSAND! But go ahead in be happy with 300 total rx. Morons!
Higher rate of heart problems with Amgen osteoporosis drug in trial
(Reuters) - Amgen Inc and UCB SA on Sunday said they do not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of serious heart-related side effects were observed in a late stage clinical trial. The drug,